| Formulation |
The Recombinant H3N2 A/ Victoria 361/2011solution contains 10mM Sodium phosphate, pH 7.1,150mM NaCl and 0.005% Tween-20. |
| Purity |
Greater than 90.0% as determined by SDS-PAGE. |
| Description |
Recombinant Full-Length H3N2 Victoria 361/2011 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells. |
| Protein Background |
H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin(H) and neuraminidase(N). H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, and influenza B. H3N2 strain descended from H2N2 by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. |
| Expression host |
Baculovirus Insect Cells. |
| Reagent Appearance |
Sterile Filtered colorless solution. |
| Stability |
H3N2 A/ Victoria 361/2011 recombinant should be stored at 4°C. Do not freeze! |
| Product Description |
Immunoreactive with all sera of HIV-1 infected individuals. |
